Oxytocin, clinical outcomes, and patient choice, in resource constrained settings
There’s an inherent tension between creating quality standards that are very clinically focussed, and standards which are very patient centred - especially in settings where clinical outcomes can be compromised by basic lack of resources.
The use of oxytocin to prevent bleeding after birth is an example of this - WHO quality guidelines clearly measure and incentivise use of the drug, but in more wealthy healthcare systems, adherence patient preference is the key measure.
How can we ensure that less wealthy healthcare systems are also patient centred?
Our guests for this discussion;
Nana Twum-Danso, senior vice pr...
Source: The BMJ Podcast - December 21, 2023 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Blood, Bleeding, and Transfusion Theme Issue
Editor’s Summary by Christopher W. Seymour, MD, MSc, Associate Editor of JAMA, the Journal of the American Medical Association, for the November 21, 2023, issue. Related Content: Audio Highlights (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - November 21, 2023 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Which is the best treatment for heavy menstrual bleeding?
In May 2022, Cochrane published the first version of an overview and network meta-analysis of interventions for heavy menstrual bleeding, which can affect 20% to 50% of people who menstruate during their reproductive years. There are a variety of treatments available, each with its pros and cons, and the best treatment is likely to depend on several factors, including age, desire to have children, personal preferences and medical history. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - February 17, 2023 Category: General Medicine Authors: Cochrane Source Type: podcasts
TWiV 916: COVID-19 clinical update #122 with Dr. Daniel Griffin
In COVID-19 clinical update #122, Dr. Griffin discusses vaccine availability and coverage among children, post-infection health impairments in children and adolescents, infection detection using salvia and nasopharyngeal samples, effectiveness of vaccines during delta dominance, durability of vaccine against severe outcomes, concern in the postvaccination era, infection rebound after Paxlovid & Molnupiravir, lack of improvement after adding ivermectin to standard care, duration of shedding of virus, how thromboprophylaxis reduces thromboembolism but increases major bleeding, multi-lineage neural and myelin dysregulation ca...
Source: This Week in Virology - MP3 Edition - July 9, 2022 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Talk Evidence covid-19 update - Research on vaccine safety, treatment for dementia
In this week's Talk Evidence, Joe Ross, BMJ editor and professor at Yale again joins Helen Macdonald to talk about emerging evidence on Covid-19.
They also welcome to the podcast Juan Franco, family physician in Buenos Aires, and professor at the Instituto Universitario Hospital Italiano, and new editor-in-chief of BMJ Evidence Based Medicine.
This week, the team bring you updates on;
Post-covid syndrome in individuals admitted to hospital with covid-19 - how are people with long covid faring.
Finally published research from Scandinavia on the risk of thrombotic events after administration of the Oxford-AstraZeneca vac...
Source: The BMJ Podcast - May 14, 2021 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Interventions available during pandemics for heavy menstrual bleeding: an overview of Cochrane Reviews
The COVID-19 pandemic has presented many challenges for healthcare systems. Interventions which were routinely delivered before 2020 are now difficult to administer and it is important to identify the effectiveness of interventions that are available. One way to do this is through focused overviews of existing reviews and this was done in July 2020 for interventions for heavy menstrual bleeding. In this podcast, Dr Martin Hirsch from University College Hospitals talks to Dr James Duffy from King ’s Fertility about the findings. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - August 6, 2020 Category: General Medicine Authors: Cochrane Source Type: podcasts
Talk Evidence - Sepsis, talc and blindsided by blinding
Welcome to the festive talk evidence, giving you a little EBM to take you into the new year. As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University ’s CEBM and editor of BMJ Evidence)*
This month:
(1.20) Carl tells us about new research on treating sepsis with steroids that might inform practice.
(4.58)Proscribing of prophylactic PPIs or H2-blockers for intensive care patients.
(11.00) Carl wonders if we can actually rule out an increased risk of ovarian cancer with the use of talc.
(17.46) Helen drops and EBM bombshell - i...
Source: The BMJ Podcast - January 22, 2020 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Talk Evidence - Sepsis, talc and blindsided by blinding
Welcome to the festive talk evidence, giving you a little EBM to take you into the new year. As always Duncan Jarvies is joined by Helen Macdonald (resting GP and editor at The BMJ) and Carl Heneghan (active GP, director of Oxford University’s CEBM and editor of BMJ Evidence)*
This month:
(1.20) Carl tells us about new research on treating sepsis with steroids that might inform practice.
(4.58)Proscribing of prophylactic PPIs or H2-blockers for intensive care patients.
(11.00) Carl wonders if we can actually rule out an increased risk of ovarian cancer with the use of talc.
(17.46) Helen drops and EBM bombshell - is...
Source: The BMJ Podcast - January 22, 2020 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Fibrinogen Concentrate vs Cryoprecipitate For Postop Bleeding, Levothyroxine for Subclinical Hypothyroidism in Older Adults, US Life Expectancy and Mortality, and more
Editor's Summary by Mary McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the November 26, 2019 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - November 26, 2019 Category: General Medicine Authors: JAMA Network Source Type: podcasts
FDA Drug Safety Podcast: FDA warns about serious bleeding risk with over-the-counter antacid products containing aspirin
(Source: FDA Drug Safety Podcasts)
Source: FDA Drug Safety Podcasts - July 12, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: podcasts
CASSINI Study Results: Reduction In Blood Clots When Taking Daily Rivaroxaban, No Increase In Bleeding
Alok Khorana, MD Of The Cleveland Clinic Discusses CASSINI Study Results: Reduction In Blood Clots When Taking Daily Rivaroxaban, No Increase In Bleeding.
Author: Annual-Meeting
Added: 06/02/2019 (Source: Oncology Tube)
Source: Oncology Tube - June 2, 2019 Category: Cancer & Oncology Source Type: podcasts
Avatrombopag: a novel oral therapy for the treatment of ITP
Idiopathic thrombocytopenic purpura or immune thrombocytopenia (ITP) is a disorder which may result in excessive bleeding or bruising due to abnormally low levels of platelet cells, leading to potenti...
Author: VJHemOnc
Added: 07/18/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 18, 2018 Category: Cancer & Oncology Source Type: podcasts
